Search all ERS
Interstitial Lung Diseases
Respiratory Critical Care
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
ERJ Open Research
European Lung White Book
All ERS guidelines
Global Lung Function Initiative
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
Autoantibodies are present in the bronchoalveolar lavage but not circulation in patients with fibrotic interstitial lung disease
Karim Boustani, Poonam Ghai, Rachele Invernizzi, Richard J. Hewitt, Toby M. Maher, Quan-Zhen Li, Philip L. Molyneaux, James A. Harker
ERJ Open Res, 8 (1) 00481-2021; 10.1183/23120541.00481-2021
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Karim Boustani, Poonam Ghai, Rachele Invernizzi, Richard J. Hewitt, Toby M. Maher, Quan-Zhen Li, Philip L. Molyneaux, James A. Harker. Autoantibodies are present in the bronchoalveolar lavage but not circulation in patients with fibrotic interstitial lung disease. ERJ Open Res, 8 (1) 00481-2021; 10.1183/23120541.00481-2021
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
No comment yet.
to comment this presentation.
Related content which might interest you:
Definition and history of sarcoidosis
Debate – Controversies in interstitial lung disease
The impact of anti-IgE treatment on the airway microbiome in asthma.
Related content which might interest you:
The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease
Source: Eur Respir Rev 2010 19: 237-241
Coagulation activity in bronchoalveolar lavage fluid and blood of interstitial lung diseases patients
Source: Eur Respir J 2003; 22: Suppl. 45, 255s
Coagulation activity of bronchoalveolar lavage fluid and blood in patients with interstitial lung diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 174s
Cytokine profile in bronchoalveolar lavage fluid of fibrotic idiopathic intersticial pneumonias compared to fibrotic intersticial pneumonias in connective tissue diseases
Source: International Congress 2016 – Connective tissue disorders
The coagulation and antifibrynolitic activities are increased in the bronchoalveolar lavage fluid from patients with progressing idiopathic pulmonary fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 575s
Can IL-4Ralpha and PAR-2 in bronchoalveolar lavage fluid serve as biomarker of fibroproliferative healing in interstitial lung diseases?
Source: International Congress 2015 – New insights into IIPs
CD163 positive alveolar macrophages from bronchoalveolar lavage in idiopathic pulmonary fibrosis and lung cancer.
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Calgranuline B in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease (DILDs)
Source: International Congress 2016 – Clinical aspects of ILD
Bronchoalveolar lavage in interstitial lung disease associated with collagen vascular disorders
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
What does bronchoalveolar lavage add to cryobiopsy in interstitial lung disease?
Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Inflammatory proteins in bronchoalveolar lavage of lung transplanted patients
Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings
Clinical significance of hemosiderin-laden macrophages in bronchoalveolar lavage fluid of patients with idiopathic interstitial pneumonias
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
High levels of pepsin A in bronchoalveolar lavage fluid of patients with exacerbation of interstitial lung diseases and no evidence of infection
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Cytofluorimetric BAL cells characterization in IPF and in other ILD
Source: International Congress 2016 – ILD: from the bench to the bedside
Influence of systemic steroid treatment on bronchoalveolar (BAL) cytological composition and cell cycle in selected interstitial lung diseases
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
The role of bronchoalveolar lavage cellular analysis in the diagnosis of interstitial lung diseases
Source: Eur Respir Mon; 2009: 46: 36–46
BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia
Source: Eur Respir J 2003; 22: 239-244
The impact of age on bronchoalveolar lavage (BAL) cytoimmunological pattern in interstitial lung diseases (ILD) and in healthy controls
Source: International Congress 2014 – ILDs 4
Source: Eur Respir Mon; 2010: 48: 59–72